Literature DB >> 8630172

Persistent hypoglycemia and hyperinsulinemia: caution in using glucagon.

M E Thoma, J Glauser, S Genuth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8630172     DOI： 10.1016/S0735-6757(96)90029-7

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN： 0735-6757            Impact factor:   2.469


× No keyword cloud information.
  4 in total

Review 1.  Octreotide's role in the management of sulfonylurea-induced hypoglycemia.

Authors:  Patrick P Dougherty; Wendy Klein-Schwartz
Journal:  J Med Toxicol       Date:  2010-06

Review 2.  Insulin & C-peptide levels in sulfonylurea-induced hypoglycemia: a systematic review.

Authors:  Christopher R DeWitt; Kennon Heard; Javier C Waksman
Journal:  J Med Toxicol       Date:  2007-09

Review 3.  Bench-to-bedside review: Antidotal treatment of sulfonylurea-induced hypoglycaemia with octreotide.

Authors:  Philippe E R Lheureux; Soheil Zahir; Andrea Penaloza; Mireille Gris
Journal:  Crit Care       Date:  2005-09-07       Impact factor: 9.097

Review 4.  Repositioning Glucagon Action in the Physiology and Pharmacology of Diabetes.

Authors:  Brian Finan; Megan E Capozzi; Jonathan E Campbell
Journal:  Diabetes       Date:  2019-06-09       Impact factor: 9.461
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.